Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Hodgson, R. Hurford, T. Harrison, D. Shaw (Nottingham, United Kingdom). Auditing patterns of azithromycin use in respiratory disease. Eur Respir J 2011; 38: Suppl. 55, 2564

Member's Comments

No comment yet.

Related content which might interest you: Rational use and stewardship of antibiotics in pediatric respiratory disease Source: ERS Courses: Paediatric respiratory infections Year: 2019 Home management of chronic respiratory disease through the use of telemedicine Source: Annual Congress 2009 - MP18 - Home management of chronic respiratory disease through the use of telemedicine Year: 2009 Improving adherence in paediatric respiratory disease Source: Breathe 2013; 9: 268-277 Year: 2013 Antibiotic prescribing in acute respiratory infections – are we following guidelines? Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006 Antibiotic treatment in pneumonia and chronic obstructive pulmonary disease – adherence to guidelines in an English teaching hospital Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines Source: Eur Respir J 2011; 37: 112-118 Year: 2011 Data-driven prescription patterns in patients under maintenance treatment for respiratory diseases from the Portuguese prescription database Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease Source: ERJ Open Res, 8 (1) 00491-2021; 10.1183/23120541.00491-2021 Year: 2022 Barriers to new drug development in respiratory disease Source: Eur Respir J 2015; 45: 1197-1207 Year: 2015 Barriers to new drug development in respiratory disease Source: Eur Respir J 2016; 47: 356-357 Year: 2016 Long-term macrolide treatment for chronic respiratory disease Source: Eur Respir J 2013; 42: 239-251 Year: 2013 Adherence to national guidelines on antibiotic prescription for COPD Source: Annual Congress 2006 - COPD therapy Year: 2006 Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia Source: Eur Respir J, 50 (3) 1602306; 10.1183/13993003.02306-2016 Year: 2017 The efficacy of antiviral therapy of acute respiratory infections in paediatric practice Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017 Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Antibiotic resistance in ambulatory patients with chronic obstructive pulmonary disease–clinical signs Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Why short-term antibiotic use in AECB may influence long-term outcomes Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Internet access and usage in patients with chronic respiratory disease Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 Antibiotic effectiveness to prevent new chronic obstructive pulmonary disease (COPD) exacerbations in current medical practice Source: Annual Congress 2009 - Functional insights into COPD Year: 2009 Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection Source: Eur Respir J 2011; 37: 119-125 Year: 2011